Income Statement (TTM)
Oryzon Genomics S.A. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 10 | 7 | 9 | 11 | 11 | 12 | 13 | 10 | 16 | 17 | 16 | 17 | 14 | 15 | 11 | 16 | 7 | 8 | 7 |
| Change (%) | -6.21 | -27.78 | 26.51 | 26.86 | -3.81 | 11.09 | 9.40 | -19.31 | 50.81 | 8.65 | -6.24 | 3.90 | -14.59 | 7.89 | -29.36 | 46.34 | -53.51 | 8.08 | -6.07 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 8.08 | -24.43 | 60.36 | -4.35 | 22.28 | 11.09 | -27.52 | 21.78 | -36.55 | 8.65 | -32.50 | 44.33 | -50.39 | 7.89 | 8.69 | -4.89 | 11.18 | 8.08 | -14.59 | |
| % of Revenue | 4.80 | 5.53 | 5.78 | 7.33 | 5.53 | 7.03 | 7.03 | 4.66 | 7.03 | 2.96 | 2.96 | 2.13 | 2.96 | 1.72 | 1.72 | 2.64 | 1.72 | 4.11 | 4.11 | 3.73 |
| Gross Operating Profit | 10 | 9 | 6 | 8 | 10 | 10 | 11 | 12 | 10 | 15 | 17 | 16 | 16 | 14 | 15 | 11 | 16 | 7 | 8 | 7 |
| Change (%) | -6.93 | -27.98 | 24.43 | 29.33 | -5.33 | 11.09 | 12.19 | -21.32 | 57.42 | 8.65 | -5.44 | 3.02 | -13.50 | 7.89 | -30.02 | 47.73 | -54.64 | 8.08 | -5.70 | |
| % of Revenue | 95.20 | 94.47 | 94.22 | 92.67 | 94.47 | 92.97 | 92.97 | 95.34 | 92.97 | 97.04 | 97.04 | 97.87 | 97.04 | 98.28 | 98.28 | 97.36 | 98.28 | 95.89 | 95.89 | 96.27 |
| SG&A | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Change (%) | 3.30 | 26.04 | -8.99 | 23.26 | -29.66 | 20.14 | -29.45 | 15.60 | -0.78 | 5.29 | -6.88 | -1.50 | 4.63 | -2.10 | 0.86 | 16.24 | -12.10 | 16.61 | 1.47 | |
| % of Revenue | 35.20 | 38.77 | 67.66 | 48.68 | 47.29 | 34.58 | 37.40 | 24.12 | 34.55 | 22.73 | 22.03 | 21.88 | 20.74 | 25.41 | 23.06 | 32.92 | 26.15 | 49.44 | 53.34 | 57.62 |
| R&D | 4 | 1 | -0 | 1 | 0 | 0 | -2 | -5 | -0 | |||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | 62.22 | 11.90 | -0.42 | 8.04 | 0.84 | 2.05 | -11.34 | -32.61 | -0.68 | |||||||||||
| OpEx | 14 | 14 | 16 | 14 | 18 | 18 | 20 | 19 | 18 | 21 | 23 | 21 | 22 | 19 | 18 | 15 | 16 | 12 | 13 | 12 |
| Change (%) | -2.09 | 17.74 | -13.43 | 29.72 | -3.47 | 11.04 | -1.24 | -7.59 | 18.65 | 8.76 | -7.92 | 5.74 | -16.43 | -3.29 | -15.59 | 3.68 | -25.28 | 10.24 | -4.41 | |
| % of Revenue | 138.96 | 145.06 | 236.51 | 161.84 | 165.49 | 166.07 | 165.99 | 149.84 | 171.61 | 135.02 | 135.16 | 132.74 | 135.08 | 132.16 | 118.47 | 141.56 | 100.29 | 161.18 | 164.40 | 167.30 |
| Operating Income | -4 | -4 | -9 | -5 | -7 | -7 | -8 | -6 | -7 | -5 | -6 | -5 | -6 | -5 | -3 | -4 | -0 | -5 | -5 | -5 |
| Change (%) | 8.48 | 118.76 | -42.68 | 34.34 | -2.96 | 10.96 | -17.37 | 15.93 | -26.26 | 9.09 | -12.70 | 11.33 | -21.70 | -38.04 | 58.98 | -98.98 | 9,734.65 | 13.77 | -1.84 | |
| % of Revenue | -38.96 | -45.06 | -136.51 | -61.84 | -65.49 | -66.07 | -65.99 | -49.84 | -71.61 | -35.02 | -35.16 | -32.74 | -35.08 | -32.16 | -18.47 | -41.56 | -0.29 | -61.18 | -64.40 | -67.30 |
| Interest Expense | -1 | -0 | -1 | -0 | -1 | -0 | -0 | -0 | -1 | -1 | -2 | -2 | -1 | -2 | -2 | -1 | -3 | -1 | -1 | -1 |
| Change (%) | -21.50 | 9.12 | -9.62 | 17.52 | -16.13 | 6.16 | 0.40 | 116.48 | 6.36 | 37.69 | 24.81 | -23.45 | 28.63 | -5.40 | -23.72 | 84.30 | -51.29 | 17.21 | -28.11 | |
| % of Revenue | -5.89 | -4.93 | -7.44 | -5.32 | -4.93 | -4.30 | -4.11 | -3.77 | -10.11 | -7.13 | -9.03 | -12.03 | -8.86 | -13.34 | -11.70 | -12.63 | -15.91 | -16.67 | -18.08 | -13.84 |
| Net Income | -3 | -3 | -5 | -3 | -4 | -5 | -5 | -5 | -3 | -4 | -5 | -4 | -4 | -3 | -3 | -4 | -5 | -4 | -5 | -4 |
| Change (%) | 5.80 | 40.27 | -35.72 | 40.34 | 8.94 | 4.24 | 1.67 | -30.28 | 22.19 | 7.70 | -23.17 | 23.49 | -22.45 | -8.01 | 24.01 | 19.11 | -19.54 | 24.37 | -7.43 | |
| % of Revenue | -31.65 | -35.71 | -69.35 | -35.24 | -38.99 | -44.15 | -41.43 | -38.50 | -33.27 | -26.95 | -26.72 | -21.89 | -26.02 | -23.63 | -20.15 | -35.36 | -28.78 | -49.81 | -57.32 | -56.48 |
Source: Capital IQ
